GTx, Inc. (NASDAQ:GTXI)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.

Recs

0
Player Avatar MajorBob04 (88.33) Submitted: 2/6/2012 3:57:34 PM : Underperform Start Price: $6.14 GTXI Score: +4.12

Short-term who knows where this one is going. Long-term, there does not appear to be anything to support the high valuation of this company.

Featured Broker Partners


Advertisement